THERAVANCE INC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THERAVANCE INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THERAVANCE INC. THERAVANCE INC is a 10% Owner in Armata Pharmaceuticals, Inc. ($APHB) and a Director in Armata Pharmaceuticals, Inc. ($APHB) and a 10% Owner in Innoviva, Inc. ($THRX) and a Director in Innoviva, Inc. ($THRX) and a 10% Owner in Theravance Biopharma, Inc. ($TBPH) and a 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX).
Address: 901 GATEWAY BLVD. SOUTH SAN FRANCISCO 94080 CA
Companies in which THERAVANCE INC is an Insider
Armata Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of THERAVANCE INC: Director, 10% Owner
Holdings: 6,153,847 shares
Current Value: $3,323,077
Latest Transaction: Mar 17 2021
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Entasis Therapeutics Holdings Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of THERAVANCE INC: 10% Owner
Holdings: 18,672,897 shares
Latest Transaction: Sep 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Innoviva, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of THERAVANCE INC: Director, 10% Owner
Holdings: 10,000,000 shares
Latest Transaction: Jun 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of THERAVANCE INC: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 19 2014
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of THERAVANCE INC
Sentiment: All, APHB, ETTX, THRX, TBPH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Option Exercise | P | 2.00 | 6,268,975 | 12,537,950 | 10,000,000 | |
| Jun 11 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | 10% Owner | Buy | P | 2.00 | 6,268,975 | 12,537,950 | 10,000,000 | 3.7 M to 10 M (+168.02 %) |
| Mar 17 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | Director | Option Exercise | P | 3.25 | 4,285,935 | 13,929,289 | 6,153,847 | |
| Mar 17 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | Director | Buy | P | 3.25 | 4,285,935 | 13,929,289 | 6,153,847 | 1.9 M to 6.2 M (+229.45 %) |
| Mar 17 2021 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | Director | Option Exercise | P | 3.25 | 4,285,935 | 13,929,289 | 6,153,847 | |
| Mar 17 2021 | APHB | Armata Pharmaceuti ... | Innoviva, Inc. | Director | Buy | P | 3.25 | 4,285,935 | 13,929,289 | 6,153,847 | 1.9 M to 6.2 M (+229.45 %) |
| Jan 28 2021 | THRX | Innoviva, Inc. | Innoviva, Inc. | Director | Option Exercise | P | 3.25 | 1,867,912 | 6,070,714 | 1,867,912 |